Clinical Development - read more

Phase I, IIa, IIb/IIIa, IIIb -
A dedicated and proven team will provide:

  • Protocol development
  • Clinical Trial Feasibility
  • Indication experience
  • Coverage
  • Central Study management
  • European central submission services
  • Risk Management Plans
  • On-site Monitoring and centralized Monitoring techniques as well as Risk-based Monitoring approaches
  • Reporting
  • Quick study set-up
  • Innovative patient recruitment support solutions

 

Find out, how AMS  Clinical Research services fit to your needs:

Talk or write to us:

ClinicalResearch bottom

• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of ther world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS ePro (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence

News

  • EMA-EUnetHTA Parallel Consultation

    EMA-EUnetHTA Parallel Consultation

    Informationen
    Artikel vom 01 August 2017 News
    Profit from the simultaneous feedback of regulatory and HTA bodies in order to generate your data set in the most efficient way! What is new? EMA and EUnetHTA h...
  • AbbVie TRIUMPH AWARD 2015

    AbbVie TRIUMPH AWARD 2015

    Informationen
    Artikel vom 24 Juni 2016 News
    Um Kooperationen auszuzeichnen und Partner entsprechend zu honorieren, verleiht AbbVie Global jährlich den Preis 'Supplier of the Year'. Kriterien, um für den P...
  • AMS ePRO

    AMS ePRO

    Informationen
    Artikel vom 01 Juni 2016 News
    The aim of the AMS -ePRO system is to enable patients to enter online (on their own smartphones, tablets or computers) their health related data in response to...